The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading bladder cancer.

Zietman, A L; Shipley, W U; Heney, N M; Althausen, A F

Zietman, A L; Shipley, W U; Heney, N M; Althausen, A F.

Affiliation

Zietman AL; Department of Radiation Oncology, Massachusetts General Hospital, Boston 02114, USA.

Semin Urol Oncol ; 15(3): 161-8, 1997 Aug.

Article in En | MEDLINE | ID: mdl-9394911

Subject(s)

Carcinoma, Transitional Cell/radiotherapy; Urinary Bladder Neoplasms/radiotherapy; Antineoplastic Agents/therapeutic use; Brachytherapy; Carcinoma, Transitional Cell/mortality; Carcinoma, Transitional Cell/therapy; Combined Modality Therapy; Female; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Invasiveness; Radiotherapy, High-Energy; Risk Factors; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms/mortality; Urinary Bladder Neoplasms/therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Semin Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 1997 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links